Parexel appoints two FDA luminaries, Dr Lola Fashoyin-Aje, and Dr Tala Fakhouri to its Consulting… EP News Bureau Jul 3, 2025 These strategic appointments will bolster the company’s regulatory expertise
FDA approves first targeted therapy to treat a rare mutation in patients with gastrointestinal… EP News Bureau Jan 10, 2020 Ayvakit is a kinase inhibitor, meaning it blocks a type of enzyme called a kinase and helps keep the cancer cells from growing
